financetom
Business
financetom
/
Business
/
Antero Resources Insider Sold Shares Worth $36,348,410, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Antero Resources Insider Sold Shares Worth $36,348,410, According to a Recent SEC Filing
Feb 21, 2025 1:18 AM

03:51 AM EST, 02/21/2025 (MT Newswires) -- W Howard Keenan Jr, Director, on February 18, 2025, sold 900,000 shares in Antero Resources ( AR ) for $36,348,410. Following the Form 4 filing with the SEC, Keenan has control over a total of 1,463,309 common shares of the company, with 363,309 shares held directly and 1,100,000 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1433270/000114036125005296/xslF345X05/form4.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Brunswick Exploration to Launch Lithium Exploration Campaign in Saudi Arabia
Brunswick Exploration to Launch Lithium Exploration Campaign in Saudi Arabia
Nov 24, 2025
08:32 AM EST, 11/24/2025 (MT Newswires) -- Brunswick Exploration ( BRWXF ) said Monday that it plans to commence a lithium exploration campaign in Saudi Arabia in the first half of 2026. As an initial entry step, Brunswick said it was awarded an exploration license in Saudi Arabia, making it the first hard-rock lithium company to embark on a country-wide...
Cidara Therapeutics Meets Target Enrollment for Phase 3 Trial of Potential Flu Preventative
Cidara Therapeutics Meets Target Enrollment for Phase 3 Trial of Potential Flu Preventative
Nov 24, 2025
08:33 AM EST, 11/24/2025 (MT Newswires) -- Cidara Therapeutics ( CDTX ) said Monday that it has reached the target enrollment of 6,000 participants in the US and UK for its phase 3 trial of CD388, a potential non-vaccine preventative of seasonal flu for patients at high risk of complications. The company said the target population includes those who are...
SEALSQ Names Ballester Lafuente as Group AI Officer
SEALSQ Names Ballester Lafuente as Group AI Officer
Nov 24, 2025
08:30 AM EST, 11/24/2025 (MT Newswires) -- SEALSQ ( LAES ) said Monday that Ballester Lafuente has been named chief of staff and group artificial intelligence officer. In this role, Lafuente will lead the integration of AI across all SEALSQ ( LAES ) group entities and coordinate cross-company initiatives aimed at streamlining operations, SEALSQ ( LAES ) said. Lafuente previously...
Ice cream only: Magnum braces for life on its own as Unilever spinoff nears
Ice cream only: Magnum braces for life on its own as Unilever spinoff nears
Nov 24, 2025
* Magnum to list in Amsterdam on December 8 * Bets on position as an ice-cream pure play * Optimistic about demand despite increasingly health-conscious consumers By Alexander Marrow GLOUCESTER, England, Nov 24 (Reuters) - Unilever's ( UL ) ice cream business is gearing up for its multi-billion-dollar spin-off next month, ready to tackle challenges from logistics to the rising...
Copyright 2023-2026 - www.financetom.com All Rights Reserved